Search

Author/Creator Wu, Tianshuang

1. Sample size considerations for comparing dynamic treatment regimens in a sequential multiple-assignment randomized trial with a continuous longitudinal outcome. (July 2020)

Authors:
Seewald, Nicholas J; Kidwell, Kelley M; Nahum-Shani, Inbal; Wu, Tianshuang; McKay, James R; Almirall, Daniel
Journal:
Statistical methods in medical research
Issue:
Volume 29:Number 7(2020)
Page Start:
1891
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab. Issue 2 (29th December 2021)

Authors:
Coates, Laura C.; Abraham, Sonya; Tillett, William; Mease, Philip J.; Ramiro, Sofia; Wu, Tianshuang; Wang, Xin; Pangan, Aileen L.; Song, In‐Ho
Journal:
Arthritis care & research
Issue:
Volume 74:Issue 2(2022)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders. (3rd October 2022)

Authors:
Strober, Bruce; Armstrong, April; Rubant, Simone; Patel, Manish; Wu, Tianshuang; Photowala, Huzefa; Crowley, Jeffrey
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 7(2022)
Page Start:
2991
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗